F2G Ltd - Company Review
F2G Ltd - Company ReviewSummary
F2G Ltd (F2G), formerly Functional Fungal Genomics Ltd, is a biotechnology company that concentrates on the development of novel drugs for the treatment of fungal diseases. The company concentrates on drugs that target fungi with high mortality rate. Its proprietary genomics technology and antifungal screening activities helped the company to identify a number of novel chemical series with potent antifungal activity. F2G also conducts research and development in the F3 series of anti mould compounds. Its F3 series compounds acts against clinically relevant aspergilli and other pathogenic moulds. The company collaborates with the University of Manchester to discover and develop new antifungal drugs. F2G is headquartered in Manchester, the UK.
This comprehensive company report of F2G Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.